Prot# 1263-300: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants

Project: Research project

Project Details

StatusFinished
Effective start/end date6/25/07 → 6/25/10

Funding

  • Shire ViroPharma Incorporated (1263-300)